A new trading day began on Tuesday, with Tarsus Pharmaceuticals Inc (NASDAQ: TARS) stock price down -4.53% from the previous day of trading, before settling in for the closing price of $41.29. TARS’s price has ranged from $20.08 to $57.28 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 63.52%. With a float of $36.27 million, this company’s outstanding shares have now reached $42.00 million.
The firm has a total of 323 workers. Let’s measure their productivity. In terms of profitability, gross margin is 92.99%, operating margin of -46.72%, and the pretax margin is -44.91%.
Tarsus Pharmaceuticals Inc (TARS) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tarsus Pharmaceuticals Inc is 13.67%, while institutional ownership is 100.89%. The most recent insider transaction that took place on Jun 17 ’25, was worth 550,088. Before that another transaction happened on Jun 16 ’25, when Company’s Chief Medical Officer sold 1,006 for $41.08, making the entire transaction worth $41,326. This insider now owns 7,694 shares in total.
Tarsus Pharmaceuticals Inc (TARS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 63.52% per share during the next fiscal year.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Trading Performance Indicators
Here are Tarsus Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.73, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach 1.22 in one year’s time.
Technical Analysis of Tarsus Pharmaceuticals Inc (TARS)
Analysing the last 5-days average volume posted by the [Tarsus Pharmaceuticals Inc, TARS], we can find that recorded value of 0.65 million was lower than the volume posted last year of 0.67 million. As of the previous 9 days, the stock’s Stochastic %D was 16.79%. Additionally, its Average True Range was 1.98.
During the past 100 days, Tarsus Pharmaceuticals Inc’s (TARS) raw stochastic average was set at 0.94%, which indicates a significant decrease from 2.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.85% in the past 14 days, which was lower than the 50.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $45.36, while its 200-day Moving Average is $45.13. Now, the first resistance to watch is $40.64. This is followed by the second major resistance level at $41.85. The third major resistance level sits at $42.55. If the price goes on to break the first support level at $38.73, it is likely to go to the next support level at $38.03. Now, if the price goes above the second support level, the third support stands at $36.82.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Key Stats
With a market capitalization of 1.66 billion, the company has a total of 42,014K Shares Outstanding. Currently, annual sales are 182,950 K while annual income is -115,550 K. The company’s previous quarter sales were 78,340 K while its latest quarter income was -25,120 K.
